Raytech Holding Limited
Explore Raytech Holding Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | The Procter & Gamble Company | $146.54 | 20.59 | $342.1 B | 3.09% | 22.93% | 31.23% | $167.25 / $137.62 | $22.21 |
| 2. | Colgate-Palmolive Company | $88.58 | 33.78 | $70.5 B | 2.49% | 44.67% | 475.13% | $99.33 / $74.55 | $0.07 |
| 3. | Kenvue Inc. | $17.71 | 20.96 | $34 B | 4.92% | 12.85% | 15.18% | $22.87 / $14.02 | $5.62 |
| 4. | Kimberly-Clark Corporation | $99.04 | 15.43 | $32.7 B | 5.42% | 23.57% | 143.64% | $137.46 / $92.42 | $4.53 |
| 5. | The Estée Lauder Companies Inc. | $83.49 | — | $30.29 B | 1.69% | 7.89% | -6.29% | $121.64 / $66.22 | $10.74 |
| 6. | Church & Dwight Co., Inc. | $96.74 | 31.03 | $22.75 B | 1.31% | 14.53% | 17.45% | $106.04 / $81.33 | $16.92 |
| 7. | The Clorox Company | $94.14 | 14.63 | $11.06 B | 5.53% | 32.32% | 453.68% | $132.03 / $84.7 | $2.62 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 78.74 M | 66.97 M | 45.52 M | 45.11 M |
| Operating Profit | 7.65 M | 11.36 M | 7.19 M | 11.18 M |
| Net Profit | 8.27 M | 9.94 M | 6.29 M | 9.44 M |
| EPS in Rs | 2.78 | 3.34 | 2.11 | 3.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 94.89 M | 58.11 M | 33.05 M | 20.88 M |
| Total Liabilities | 17.93 M | 27.04 M | 11.91 M | 6.04 M |
| Equity | 76.96 M | 31.08 M | 21.14 M | 14.85 M |
| Current Assets | 94.87 M | 52.84 M | 29.75 M | 20.65 M |
| Current Liabilities | 17.93 M | 27.04 M | 11.91 M | 5.95 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 6.22 M | 15.75 M | 10.96 M | 8.23 M |
| Investing CF | 0.15 M | 0.85 M | 1.44 M | 2.2 M |
| Financing CF | 42.87 M | -2.08 M | -3.18 M | -1.56 M |
| Free CF | 6.22 M | 15.75 M | 10.96 M | 8.22 M |
| Capex | — | — | — | -0.01 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 17.57% | 47.13% | 0.91% | — |
| Earnings Growth % | -16.79% | 57.91% | -33.34% | — |
| Profit Margin % | 10.5% | 14.84% | 13.82% | 20.93% |
| Operating Margin % | 9.71% | 16.96% | 15.81% | 24.78% |
| Gross Margin % | 22.62% | 22.26% | 25.2% | 26.84% |
| EBITDA Margin % | 13.37% | 19.18% | 16.69% | 24.87% |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-11-07 | 1:0.0625 |
Frequently Asked Questions — Raytech Holding Limited
Will Raytech Holding Limited stock hit $4 in 2026?
Raytech Holding Limited (RAY) is currently trading at $3.07, with a 52-week range of $1.4 to $58.88. Reaching the $4 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.
Whether Raytech Holding Limited can reach $4 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Consumer Defensive space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.
Short-term price predictions carry significant uncertainty — stock prices can be influenced by factors ranging from quarterly earnings surprises to global macroeconomic events. Use the RAY Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.
Is Raytech Holding Limited stock worth buying at $3.07?
Whether Raytech Holding Limited (RAY) is worth buying at $3.07 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:
Valuation: Raytech Holding Limited trades at a Price-to-Earnings (P/E) ratio of 5.4x, which can be compared against other Consumer Defensive companies to assess whether the stock is expensive or attractively priced relative to its peers.
Profitability & efficiency: Raytech Holding Limited has a Return on Capital Employed (ROCE) of 9.9%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at 13.4%.
Financial health: Review the balance sheet section on StockSifting for the latest debt levels, cash reserves, and liquidity ratios.
Analyst view: Analyst estimates are not currently available for RAY. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.
What is the analyst price target for Raytech Holding Limited (RAY) in 2026?
Analyst price target data for Raytech Holding Limited (RAY) is not currently available on StockSifting. Analyst coverage and price targets are typically published by brokerage research desks for widely followed stocks, and are updated regularly after earnings results or major corporate events. Check back for the latest estimates, or explore RAY's financial ratios, historical returns, and fundamental data available on this page to form your own view.
Is Raytech Holding Limited overvalued at a P/E ratio of 5.4x?
Raytech Holding Limited (RAY) currently has a Price-to-Earnings (P/E) ratio of 5.4x, meaning investors are paying $5.4 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:
Sector context: The Consumer Defensive sector tends to command higher valuation multiples when growth expectations are elevated. A 5.4x P/E is relatively low, which could indicate an undervalued opportunity — or it may reflect lower expected growth or higher perceived risk.
Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation. Raytech Holding Limited's ROCE of 9.9% suggests it has moderate capital returns.
Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of RAY's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.
What will Raytech Holding Limited stock be worth in 2029?
Projecting Raytech Holding Limited (RAY)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.
In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.
You can model different scenarios — conservative, base, and bull case — using the RAY Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.